nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Benzphetamine—Tamoxifen—pancreatic cancer	0.465	1	CrCrCtD
Dextroamphetamine—Dyspnoea—Erlotinib—pancreatic cancer	0.00114	0.00339	CcSEcCtD
Dextroamphetamine—Dyspepsia—Tamoxifen—pancreatic cancer	0.00113	0.00338	CcSEcCtD
Dextroamphetamine—Dry mouth—Sunitinib—pancreatic cancer	0.00113	0.00336	CcSEcCtD
Dextroamphetamine—Dyspepsia—Erlotinib—pancreatic cancer	0.00112	0.00335	CcSEcCtD
Dextroamphetamine—Decreased appetite—Tamoxifen—pancreatic cancer	0.00112	0.00334	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00111	0.00332	CcSEcCtD
Dextroamphetamine—Fatigue—Tamoxifen—pancreatic cancer	0.00111	0.00331	CcSEcCtD
Dextroamphetamine—Decreased appetite—Erlotinib—pancreatic cancer	0.00111	0.00331	CcSEcCtD
Dextroamphetamine—Constipation—Tamoxifen—pancreatic cancer	0.0011	0.00329	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.0011	0.00328	CcSEcCtD
Dextroamphetamine—Fatigue—Erlotinib—pancreatic cancer	0.0011	0.00328	CcSEcCtD
Dextroamphetamine—Infection—Sunitinib—pancreatic cancer	0.0011	0.00327	CcSEcCtD
Dextroamphetamine—Constipation—Erlotinib—pancreatic cancer	0.00109	0.00325	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00105	0.00314	CcSEcCtD
Dextroamphetamine—Anorexia—Sunitinib—pancreatic cancer	0.00105	0.00314	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00104	0.00311	CcSEcCtD
Dextroamphetamine—Urticaria—Tamoxifen—pancreatic cancer	0.00102	0.00305	CcSEcCtD
Dextroamphetamine—Abdominal pain—Tamoxifen—pancreatic cancer	0.00102	0.00304	CcSEcCtD
Dextroamphetamine—Abdominal pain—Erlotinib—pancreatic cancer	0.00101	0.00301	CcSEcCtD
Dextroamphetamine—Body temperature increased—Erlotinib—pancreatic cancer	0.00101	0.00301	CcSEcCtD
Dextroamphetamine—Weight decreased—Docetaxel—pancreatic cancer	0.001	0.00298	CcSEcCtD
Dextroamphetamine—Insomnia—Sunitinib—pancreatic cancer	0.000998	0.00298	CcSEcCtD
Dextroamphetamine—Dyspnoea—Sunitinib—pancreatic cancer	0.000984	0.00294	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000977	0.00291	CcSEcCtD
Dextroamphetamine—Dyspepsia—Sunitinib—pancreatic cancer	0.000971	0.0029	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000971	0.0029	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Docetaxel—pancreatic cancer	0.000966	0.00288	CcSEcCtD
Dextroamphetamine—Hypertension—Irinotecan—pancreatic cancer	0.000961	0.00287	CcSEcCtD
Dextroamphetamine—Decreased appetite—Sunitinib—pancreatic cancer	0.000959	0.00286	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000953	0.00284	CcSEcCtD
Dextroamphetamine—Fatigue—Sunitinib—pancreatic cancer	0.000951	0.00284	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000949	0.00283	CcSEcCtD
Dextroamphetamine—Constipation—Sunitinib—pancreatic cancer	0.000943	0.00282	CcSEcCtD
Dextroamphetamine—Hypertension—Gemcitabine—pancreatic cancer	0.000937	0.00279	CcSEcCtD
Dextroamphetamine—Asthenia—Tamoxifen—pancreatic cancer	0.000924	0.00276	CcSEcCtD
Dextroamphetamine—Convulsion—Fluorouracil—pancreatic cancer	0.000924	0.00276	CcSEcCtD
Dextroamphetamine—Chest pain—Gemcitabine—pancreatic cancer	0.000923	0.00276	CcSEcCtD
Dextroamphetamine—Asthenia—Erlotinib—pancreatic cancer	0.000914	0.00273	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000909	0.00271	CcSEcCtD
Dextroamphetamine—Chest pain—Fluorouracil—pancreatic cancer	0.000908	0.00271	CcSEcCtD
Dextroamphetamine—Infection—Irinotecan—pancreatic cancer	0.000903	0.00269	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000902	0.00269	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000885	0.00264	CcSEcCtD
Dextroamphetamine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000881	0.00263	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.00088	0.00263	CcSEcCtD
Dextroamphetamine—Infection—Gemcitabine—pancreatic cancer	0.00088	0.00262	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000879	0.00262	CcSEcCtD
Dextroamphetamine—Abdominal pain—Sunitinib—pancreatic cancer	0.000872	0.0026	CcSEcCtD
Dextroamphetamine—Body temperature increased—Sunitinib—pancreatic cancer	0.000872	0.0026	CcSEcCtD
Dextroamphetamine—Diarrhoea—Erlotinib—pancreatic cancer	0.000872	0.0026	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00087	0.0026	CcSEcCtD
Dextroamphetamine—Anorexia—Irinotecan—pancreatic cancer	0.000866	0.00259	CcSEcCtD
Dextroamphetamine—Infection—Fluorouracil—pancreatic cancer	0.000865	0.00258	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000856	0.00255	CcSEcCtD
Dextroamphetamine—Dizziness—Tamoxifen—pancreatic cancer	0.000852	0.00254	CcSEcCtD
Dextroamphetamine—Tachycardia—Fluorouracil—pancreatic cancer	0.00085	0.00254	CcSEcCtD
Dextroamphetamine—Affect lability—Epirubicin—pancreatic cancer	0.000849	0.00253	CcSEcCtD
Dextroamphetamine—Anorexia—Gemcitabine—pancreatic cancer	0.000844	0.00252	CcSEcCtD
Dextroamphetamine—Dizziness—Erlotinib—pancreatic cancer	0.000843	0.00252	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Docetaxel—pancreatic cancer	0.000836	0.0025	CcSEcCtD
Dextroamphetamine—Anorexia—Fluorouracil—pancreatic cancer	0.00083	0.00248	CcSEcCtD
Dextroamphetamine—Insomnia—Irinotecan—pancreatic cancer	0.000822	0.00245	CcSEcCtD
Dextroamphetamine—Vomiting—Tamoxifen—pancreatic cancer	0.000819	0.00244	CcSEcCtD
Dextroamphetamine—Mood swings—Epirubicin—pancreatic cancer	0.000817	0.00244	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000814	0.00243	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000813	0.00243	CcSEcCtD
Dextroamphetamine—Rash—Tamoxifen—pancreatic cancer	0.000812	0.00242	CcSEcCtD
Dextroamphetamine—Dermatitis—Tamoxifen—pancreatic cancer	0.000811	0.00242	CcSEcCtD
Dextroamphetamine—Vomiting—Erlotinib—pancreatic cancer	0.00081	0.00242	CcSEcCtD
Dextroamphetamine—Dyspnoea—Irinotecan—pancreatic cancer	0.00081	0.00242	CcSEcCtD
Dextroamphetamine—Somnolence—Irinotecan—pancreatic cancer	0.000808	0.00241	CcSEcCtD
Dextroamphetamine—Headache—Tamoxifen—pancreatic cancer	0.000807	0.00241	CcSEcCtD
Dextroamphetamine—Rash—Erlotinib—pancreatic cancer	0.000804	0.0024	CcSEcCtD
Dextroamphetamine—Dermatitis—Erlotinib—pancreatic cancer	0.000803	0.0024	CcSEcCtD
Dextroamphetamine—Insomnia—Gemcitabine—pancreatic cancer	0.000801	0.00239	CcSEcCtD
Dextroamphetamine—Dyspepsia—Irinotecan—pancreatic cancer	0.0008	0.00239	CcSEcCtD
Dextroamphetamine—Headache—Erlotinib—pancreatic cancer	0.000798	0.00238	CcSEcCtD
Dextroamphetamine—Asthenia—Sunitinib—pancreatic cancer	0.000792	0.00236	CcSEcCtD
Dextroamphetamine—Decreased appetite—Irinotecan—pancreatic cancer	0.00079	0.00236	CcSEcCtD
Dextroamphetamine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000789	0.00236	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000787	0.00235	CcSEcCtD
Dextroamphetamine—Insomnia—Fluorouracil—pancreatic cancer	0.000787	0.00235	CcSEcCtD
Dextroamphetamine—Somnolence—Gemcitabine—pancreatic cancer	0.000787	0.00235	CcSEcCtD
Dextroamphetamine—Affect lability—Doxorubicin—pancreatic cancer	0.000785	0.00234	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000785	0.00234	CcSEcCtD
Dextroamphetamine—Fatigue—Irinotecan—pancreatic cancer	0.000784	0.00234	CcSEcCtD
Dextroamphetamine—Constipation—Irinotecan—pancreatic cancer	0.000777	0.00232	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000776	0.00232	CcSEcCtD
Dextroamphetamine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000776	0.00232	CcSEcCtD
Dextroamphetamine—Somnolence—Fluorouracil—pancreatic cancer	0.000774	0.00231	CcSEcCtD
Dextroamphetamine—Decreased appetite—Gemcitabine—pancreatic cancer	0.00077	0.0023	CcSEcCtD
Dextroamphetamine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000766	0.00229	CcSEcCtD
Dextroamphetamine—Nausea—Tamoxifen—pancreatic cancer	0.000765	0.00228	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000764	0.00228	CcSEcCtD
Dextroamphetamine—Fatigue—Gemcitabine—pancreatic cancer	0.000763	0.00228	CcSEcCtD
Dextroamphetamine—Constipation—Gemcitabine—pancreatic cancer	0.000757	0.00226	CcSEcCtD
Dextroamphetamine—Nausea—Erlotinib—pancreatic cancer	0.000757	0.00226	CcSEcCtD
Dextroamphetamine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000757	0.00226	CcSEcCtD
Dextroamphetamine—Mood swings—Doxorubicin—pancreatic cancer	0.000756	0.00226	CcSEcCtD
Dextroamphetamine—Diarrhoea—Sunitinib—pancreatic cancer	0.000755	0.00225	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000751	0.00224	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000743	0.00222	CcSEcCtD
Dextroamphetamine—Dizziness—Sunitinib—pancreatic cancer	0.00073	0.00218	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000729	0.00217	CcSEcCtD
Dextroamphetamine—Body temperature increased—Irinotecan—pancreatic cancer	0.000718	0.00214	CcSEcCtD
Dextroamphetamine—Abdominal pain—Irinotecan—pancreatic cancer	0.000718	0.00214	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000718	0.00214	CcSEcCtD
Dextroamphetamine—Vomiting—Sunitinib—pancreatic cancer	0.000702	0.00209	CcSEcCtD
Dextroamphetamine—Body temperature increased—Gemcitabine—pancreatic cancer	0.0007	0.00209	CcSEcCtD
Dextroamphetamine—Rash—Sunitinib—pancreatic cancer	0.000696	0.00208	CcSEcCtD
Dextroamphetamine—Dermatitis—Sunitinib—pancreatic cancer	0.000695	0.00207	CcSEcCtD
Dextroamphetamine—Urticaria—Fluorouracil—pancreatic cancer	0.000691	0.00206	CcSEcCtD
Dextroamphetamine—Headache—Sunitinib—pancreatic cancer	0.000691	0.00206	CcSEcCtD
Dextroamphetamine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000688	0.00205	CcSEcCtD
Dextroamphetamine—Palpitations—Docetaxel—pancreatic cancer	0.00068	0.00203	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00068	0.00203	CcSEcCtD
Dextroamphetamine—Weight decreased—Epirubicin—pancreatic cancer	0.000674	0.00201	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00067	0.002	CcSEcCtD
Dextroamphetamine—Convulsion—Docetaxel—pancreatic cancer	0.000667	0.00199	CcSEcCtD
Dextroamphetamine—Hypertension—Docetaxel—pancreatic cancer	0.000665	0.00198	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000659	0.00197	CcSEcCtD
Dextroamphetamine—Chest pain—Docetaxel—pancreatic cancer	0.000655	0.00196	CcSEcCtD
Dextroamphetamine—Nausea—Sunitinib—pancreatic cancer	0.000655	0.00196	CcSEcCtD
Dextroamphetamine—Asthenia—Irinotecan—pancreatic cancer	0.000652	0.00195	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000646	0.00193	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000641	0.00191	CcSEcCtD
Dextroamphetamine—Dry mouth—Docetaxel—pancreatic cancer	0.000641	0.00191	CcSEcCtD
Dextroamphetamine—Sweating—Epirubicin—pancreatic cancer	0.000637	0.0019	CcSEcCtD
Dextroamphetamine—Asthenia—Gemcitabine—pancreatic cancer	0.000635	0.0019	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000629	0.00188	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000628	0.00187	CcSEcCtD
Dextroamphetamine—Infection—Docetaxel—pancreatic cancer	0.000624	0.00186	CcSEcCtD
Dextroamphetamine—Weight decreased—Doxorubicin—pancreatic cancer	0.000624	0.00186	CcSEcCtD
Dextroamphetamine—Diarrhoea—Irinotecan—pancreatic cancer	0.000622	0.00186	CcSEcCtD
Dextroamphetamine—Tachycardia—Docetaxel—pancreatic cancer	0.000613	0.00183	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000609	0.00182	CcSEcCtD
Dextroamphetamine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000606	0.00181	CcSEcCtD
Dextroamphetamine—Dizziness—Irinotecan—pancreatic cancer	0.000601	0.00179	CcSEcCtD
Dextroamphetamine—Anorexia—Docetaxel—pancreatic cancer	0.000599	0.00179	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000598	0.00178	CcSEcCtD
Dextroamphetamine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000596	0.00178	CcSEcCtD
Dextroamphetamine—Sweating—Doxorubicin—pancreatic cancer	0.000589	0.00176	CcSEcCtD
Dextroamphetamine—Vomiting—Irinotecan—pancreatic cancer	0.000578	0.00172	CcSEcCtD
Dextroamphetamine—Dizziness—Fluorouracil—pancreatic cancer	0.000576	0.00172	CcSEcCtD
Dextroamphetamine—Rash—Irinotecan—pancreatic cancer	0.000573	0.00171	CcSEcCtD
Dextroamphetamine—Dermatitis—Irinotecan—pancreatic cancer	0.000573	0.00171	CcSEcCtD
Dextroamphetamine—Headache—Irinotecan—pancreatic cancer	0.000569	0.0017	CcSEcCtD
Dextroamphetamine—Insomnia—Docetaxel—pancreatic cancer	0.000568	0.0017	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000564	0.00168	CcSEcCtD
Dextroamphetamine—Vomiting—Gemcitabine—pancreatic cancer	0.000563	0.00168	CcSEcCtD
Dextroamphetamine—Dyspnoea—Docetaxel—pancreatic cancer	0.00056	0.00167	CcSEcCtD
Dextroamphetamine—Somnolence—Docetaxel—pancreatic cancer	0.000559	0.00167	CcSEcCtD
Dextroamphetamine—Rash—Gemcitabine—pancreatic cancer	0.000558	0.00167	CcSEcCtD
Dextroamphetamine—Dermatitis—Gemcitabine—pancreatic cancer	0.000558	0.00166	CcSEcCtD
Dextroamphetamine—Headache—Gemcitabine—pancreatic cancer	0.000555	0.00166	CcSEcCtD
Dextroamphetamine—Vomiting—Fluorouracil—pancreatic cancer	0.000553	0.00165	CcSEcCtD
Dextroamphetamine—Dyspepsia—Docetaxel—pancreatic cancer	0.000553	0.00165	CcSEcCtD
Dextroamphetamine—Rash—Fluorouracil—pancreatic cancer	0.000549	0.00164	CcSEcCtD
Dextroamphetamine—Dermatitis—Fluorouracil—pancreatic cancer	0.000548	0.00164	CcSEcCtD
Dextroamphetamine—Decreased appetite—Docetaxel—pancreatic cancer	0.000546	0.00163	CcSEcCtD
Dextroamphetamine—Headache—Fluorouracil—pancreatic cancer	0.000545	0.00163	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000542	0.00162	CcSEcCtD
Dextroamphetamine—Fatigue—Docetaxel—pancreatic cancer	0.000542	0.00162	CcSEcCtD
Dextroamphetamine—Nausea—Irinotecan—pancreatic cancer	0.00054	0.00161	CcSEcCtD
Dextroamphetamine—Constipation—Docetaxel—pancreatic cancer	0.000537	0.0016	CcSEcCtD
Dextroamphetamine—Nausea—Gemcitabine—pancreatic cancer	0.000526	0.00157	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000522	0.00156	CcSEcCtD
Dextroamphetamine—Nausea—Fluorouracil—pancreatic cancer	0.000517	0.00154	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000514	0.00153	CcSEcCtD
Dextroamphetamine—Tension—Epirubicin—pancreatic cancer	0.00051	0.00152	CcSEcCtD
Dextroamphetamine—Nervousness—Epirubicin—pancreatic cancer	0.000504	0.0015	CcSEcCtD
Dextroamphetamine—Abdominal pain—Docetaxel—pancreatic cancer	0.000497	0.00148	CcSEcCtD
Dextroamphetamine—Body temperature increased—Docetaxel—pancreatic cancer	0.000497	0.00148	CcSEcCtD
Dextroamphetamine—Agitation—Epirubicin—pancreatic cancer	0.000477	0.00142	CcSEcCtD
Dextroamphetamine—Tension—Doxorubicin—pancreatic cancer	0.000471	0.00141	CcSEcCtD
Dextroamphetamine—Nervousness—Doxorubicin—pancreatic cancer	0.000467	0.00139	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000463	0.00138	CcSEcCtD
Dextroamphetamine—Palpitations—Epirubicin—pancreatic cancer	0.000459	0.00137	CcSEcCtD
Dextroamphetamine—Asthenia—Docetaxel—pancreatic cancer	0.000451	0.00135	CcSEcCtD
Dextroamphetamine—Convulsion—Epirubicin—pancreatic cancer	0.00045	0.00134	CcSEcCtD
Dextroamphetamine—Hypertension—Epirubicin—pancreatic cancer	0.000448	0.00134	CcSEcCtD
Dextroamphetamine—Chest pain—Epirubicin—pancreatic cancer	0.000442	0.00132	CcSEcCtD
Dextroamphetamine—Agitation—Doxorubicin—pancreatic cancer	0.000441	0.00132	CcSEcCtD
Dextroamphetamine—Anxiety—Epirubicin—pancreatic cancer	0.000441	0.00131	CcSEcCtD
Dextroamphetamine—Dry mouth—Epirubicin—pancreatic cancer	0.000432	0.00129	CcSEcCtD
Dextroamphetamine—Diarrhoea—Docetaxel—pancreatic cancer	0.00043	0.00128	CcSEcCtD
Dextroamphetamine—Palpitations—Doxorubicin—pancreatic cancer	0.000425	0.00127	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000424	0.00126	CcSEcCtD
Dextroamphetamine—Infection—Epirubicin—pancreatic cancer	0.000421	0.00126	CcSEcCtD
Dextroamphetamine—Convulsion—Doxorubicin—pancreatic cancer	0.000416	0.00124	CcSEcCtD
Dextroamphetamine—Dizziness—Docetaxel—pancreatic cancer	0.000415	0.00124	CcSEcCtD
Dextroamphetamine—Hypertension—Doxorubicin—pancreatic cancer	0.000415	0.00124	CcSEcCtD
Dextroamphetamine—Tachycardia—Epirubicin—pancreatic cancer	0.000414	0.00123	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.00041	0.00122	CcSEcCtD
Dextroamphetamine—Chest pain—Doxorubicin—pancreatic cancer	0.000409	0.00122	CcSEcCtD
Dextroamphetamine—Anxiety—Doxorubicin—pancreatic cancer	0.000408	0.00122	CcSEcCtD
Dextroamphetamine—Anorexia—Epirubicin—pancreatic cancer	0.000404	0.00121	CcSEcCtD
Dextroamphetamine—Dry mouth—Doxorubicin—pancreatic cancer	0.0004	0.00119	CcSEcCtD
Dextroamphetamine—Vomiting—Docetaxel—pancreatic cancer	0.000399	0.00119	CcSEcCtD
Dextroamphetamine—Rash—Docetaxel—pancreatic cancer	0.000396	0.00118	CcSEcCtD
Dextroamphetamine—Dermatitis—Docetaxel—pancreatic cancer	0.000396	0.00118	CcSEcCtD
Dextroamphetamine—Headache—Docetaxel—pancreatic cancer	0.000394	0.00117	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000392	0.00117	CcSEcCtD
Dextroamphetamine—Infection—Doxorubicin—pancreatic cancer	0.00039	0.00116	CcSEcCtD
Dextroamphetamine—Insomnia—Epirubicin—pancreatic cancer	0.000383	0.00114	CcSEcCtD
Dextroamphetamine—Tachycardia—Doxorubicin—pancreatic cancer	0.000383	0.00114	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000379	0.00113	CcSEcCtD
Dextroamphetamine—Dyspnoea—Epirubicin—pancreatic cancer	0.000378	0.00113	CcSEcCtD
Dextroamphetamine—Somnolence—Epirubicin—pancreatic cancer	0.000377	0.00112	CcSEcCtD
Dextroamphetamine—Anorexia—Doxorubicin—pancreatic cancer	0.000374	0.00112	CcSEcCtD
Dextroamphetamine—Nausea—Docetaxel—pancreatic cancer	0.000373	0.00111	CcSEcCtD
Dextroamphetamine—Dyspepsia—Epirubicin—pancreatic cancer	0.000373	0.00111	CcSEcCtD
Dextroamphetamine—Decreased appetite—Epirubicin—pancreatic cancer	0.000368	0.0011	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000366	0.00109	CcSEcCtD
Dextroamphetamine—Fatigue—Epirubicin—pancreatic cancer	0.000365	0.00109	CcSEcCtD
Dextroamphetamine—Constipation—Epirubicin—pancreatic cancer	0.000362	0.00108	CcSEcCtD
Dextroamphetamine—Insomnia—Doxorubicin—pancreatic cancer	0.000355	0.00106	CcSEcCtD
Dextroamphetamine—Dyspnoea—Doxorubicin—pancreatic cancer	0.00035	0.00104	CcSEcCtD
Dextroamphetamine—Somnolence—Doxorubicin—pancreatic cancer	0.000349	0.00104	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000347	0.00103	CcSEcCtD
Dextroamphetamine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000345	0.00103	CcSEcCtD
Dextroamphetamine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000341	0.00102	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000339	0.00101	CcSEcCtD
Dextroamphetamine—Fatigue—Doxorubicin—pancreatic cancer	0.000338	0.00101	CcSEcCtD
Dextroamphetamine—Urticaria—Epirubicin—pancreatic cancer	0.000337	0.001	CcSEcCtD
Dextroamphetamine—Constipation—Doxorubicin—pancreatic cancer	0.000335	0.001	CcSEcCtD
Dextroamphetamine—Abdominal pain—Epirubicin—pancreatic cancer	0.000335	0.001	CcSEcCtD
Dextroamphetamine—Body temperature increased—Epirubicin—pancreatic cancer	0.000335	0.001	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000321	0.000957	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000312	0.000932	CcSEcCtD
Dextroamphetamine—Urticaria—Doxorubicin—pancreatic cancer	0.000311	0.00093	CcSEcCtD
Dextroamphetamine—Abdominal pain—Doxorubicin—pancreatic cancer	0.00031	0.000925	CcSEcCtD
Dextroamphetamine—Body temperature increased—Doxorubicin—pancreatic cancer	0.00031	0.000925	CcSEcCtD
Dextroamphetamine—Asthenia—Epirubicin—pancreatic cancer	0.000304	0.000907	CcSEcCtD
Dextroamphetamine—Diarrhoea—Epirubicin—pancreatic cancer	0.00029	0.000865	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000289	0.000862	CcSEcCtD
Dextroamphetamine—Asthenia—Doxorubicin—pancreatic cancer	0.000281	0.00084	CcSEcCtD
Dextroamphetamine—Dizziness—Epirubicin—pancreatic cancer	0.00028	0.000836	CcSEcCtD
Dextroamphetamine—Vomiting—Epirubicin—pancreatic cancer	0.000269	0.000804	CcSEcCtD
Dextroamphetamine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000268	0.000801	CcSEcCtD
Dextroamphetamine—Rash—Epirubicin—pancreatic cancer	0.000267	0.000797	CcSEcCtD
Dextroamphetamine—Dermatitis—Epirubicin—pancreatic cancer	0.000267	0.000797	CcSEcCtD
Dextroamphetamine—Headache—Epirubicin—pancreatic cancer	0.000265	0.000792	CcSEcCtD
Dextroamphetamine—Dizziness—Doxorubicin—pancreatic cancer	0.000259	0.000774	CcSEcCtD
Dextroamphetamine—Nausea—Epirubicin—pancreatic cancer	0.000252	0.000751	CcSEcCtD
Dextroamphetamine—Vomiting—Doxorubicin—pancreatic cancer	0.000249	0.000744	CcSEcCtD
Dextroamphetamine—Rash—Doxorubicin—pancreatic cancer	0.000247	0.000738	CcSEcCtD
Dextroamphetamine—Dermatitis—Doxorubicin—pancreatic cancer	0.000247	0.000737	CcSEcCtD
Dextroamphetamine—Headache—Doxorubicin—pancreatic cancer	0.000246	0.000733	CcSEcCtD
Dextroamphetamine—Nausea—Doxorubicin—pancreatic cancer	0.000233	0.000695	CcSEcCtD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IAPP—pancreatic cancer	0.000111	0.000556	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—EGFR—pancreatic cancer	0.00011	0.00055	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DTX1—pancreatic cancer	0.00011	0.000549	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SSTR3—pancreatic cancer	0.00011	0.000549	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCKAR—pancreatic cancer	0.00011	0.000549	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IAPP—pancreatic cancer	0.000109	0.000544	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ZNRF3—pancreatic cancer	0.000108	0.000539	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ACVR1B—pancreatic cancer	0.000108	0.000539	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—SST—pancreatic cancer	0.000108	0.000538	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTHLH—pancreatic cancer	0.000107	0.000534	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTCH1—pancreatic cancer	0.000107	0.000534	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000106	0.00053	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000105	0.000528	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SSTR1—pancreatic cancer	0.000105	0.000527	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000105	0.000525	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000104	0.000522	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—KRAS—pancreatic cancer	0.000104	0.000519	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PPY—pancreatic cancer	0.000103	0.000516	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SSTR2—pancreatic cancer	0.000101	0.000507	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—SHH—pancreatic cancer	0.0001	0.0005	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CNR1—pancreatic cancer	9.93e-05	0.000496	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IAPP—pancreatic cancer	9.88e-05	0.000494	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCKBR—pancreatic cancer	9.79e-05	0.00049	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—SST—pancreatic cancer	9.77e-05	0.000488	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SSTR3—pancreatic cancer	9.76e-05	0.000488	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DTX1—pancreatic cancer	9.76e-05	0.000488	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	9.74e-05	0.000487	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	9.61e-05	0.000481	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—GCG—pancreatic cancer	9.59e-05	0.000479	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—SST—pancreatic cancer	9.55e-05	0.000478	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—PIK3CA—pancreatic cancer	9.54e-05	0.000477	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTHLH—pancreatic cancer	9.49e-05	0.000474	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTCH1—pancreatic cancer	9.49e-05	0.000474	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	9.39e-05	0.000469	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	9.37e-05	0.000469	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SSTR1—pancreatic cancer	9.35e-05	0.000468	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—PIK3CA—pancreatic cancer	9.33e-05	0.000466	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CB—pancreatic cancer	9.25e-05	0.000462	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DTX4—pancreatic cancer	9.2e-05	0.00046	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GLI1—pancreatic cancer	9.2e-05	0.00046	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PPY—pancreatic cancer	9.17e-05	0.000459	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AGTR1—pancreatic cancer	9.15e-05	0.000457	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	9.08e-05	0.000454	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CNR1—pancreatic cancer	9.01e-05	0.000451	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SSTR2—pancreatic cancer	9e-05	0.00045	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NRP1—pancreatic cancer	8.95e-05	0.000448	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PPP2R5B—pancreatic cancer	8.95e-05	0.000448	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCL8—pancreatic cancer	8.89e-05	0.000444	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HRAS—pancreatic cancer	8.83e-05	0.000441	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CNR1—pancreatic cancer	8.82e-05	0.000441	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—GCG—pancreatic cancer	8.71e-05	0.000435	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCKBR—pancreatic cancer	8.7e-05	0.000435	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—SST—pancreatic cancer	8.68e-05	0.000434	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	8.65e-05	0.000432	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HEY2—pancreatic cancer	8.62e-05	0.000431	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—AKT1—pancreatic cancer	8.58e-05	0.000429	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	8.54e-05	0.000427	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—GCG—pancreatic cancer	8.52e-05	0.000426	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CASP3—pancreatic cancer	8.51e-05	0.000425	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GAST—pancreatic cancer	8.42e-05	0.000421	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	8.34e-05	0.000417	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AGTR1—pancreatic cancer	8.31e-05	0.000415	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	8.28e-05	0.000414	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CCND1—pancreatic cancer	8.28e-05	0.000414	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CTNNB1—pancreatic cancer	8.2e-05	0.00041	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DTX4—pancreatic cancer	8.18e-05	0.000409	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GLI1—pancreatic cancer	8.18e-05	0.000409	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AGTR1—pancreatic cancer	8.12e-05	0.000406	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	8.07e-05	0.000403	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MMP9—pancreatic cancer	8.04e-05	0.000402	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CNR1—pancreatic cancer	8.01e-05	0.0004	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PTEN—pancreatic cancer	7.99e-05	0.0004	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SCT—pancreatic cancer	7.98e-05	0.000399	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HEY1—pancreatic cancer	7.98e-05	0.000399	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PPP2R5B—pancreatic cancer	7.95e-05	0.000398	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NRP1—pancreatic cancer	7.95e-05	0.000398	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	7.81e-05	0.000391	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—AKT1—pancreatic cancer	7.8e-05	0.00039	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—GCG—pancreatic cancer	7.73e-05	0.000387	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	7.72e-05	0.000386	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HEY2—pancreatic cancer	7.66e-05	0.000383	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCK—pancreatic cancer	7.61e-05	0.000381	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	7.48e-05	0.000374	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CNR2—pancreatic cancer	7.42e-05	0.000371	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GLP1R—pancreatic cancer	7.42e-05	0.000371	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL8—pancreatic cancer	7.42e-05	0.000371	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—SRC—pancreatic cancer	7.41e-05	0.000371	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	7.41e-05	0.000371	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	7.38e-05	0.000369	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCKAR—pancreatic cancer	7.3e-05	0.000365	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VEGFA—pancreatic cancer	7.22e-05	0.000361	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Neuronal System—HRAS—pancreatic cancer	7.19e-05	0.00036	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STAT3—pancreatic cancer	7.15e-05	0.000357	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NRAS—pancreatic cancer	7.13e-05	0.000356	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	7.09e-05	0.000354	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	7.09e-05	0.000354	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JAG2—pancreatic cancer	7.08e-05	0.000354	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MEN1—pancreatic cancer	6.98e-05	0.000349	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	6.86e-05	0.000343	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ARG2—pancreatic cancer	6.77e-05	0.000339	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	6.76e-05	0.000338	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SHH—pancreatic cancer	6.65e-05	0.000333	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MYC—pancreatic cancer	6.64e-05	0.000332	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TGFB1—pancreatic cancer	6.62e-05	0.000331	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH4—pancreatic cancer	6.61e-05	0.000331	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	6.59e-05	0.00033	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	6.59e-05	0.00033	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	6.59e-05	0.000329	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IAPP—pancreatic cancer	6.57e-05	0.000329	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EGFR—pancreatic cancer	6.5e-05	0.000325	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	6.48e-05	0.000324	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTHLH—pancreatic cancer	6.31e-05	0.000315	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTCH1—pancreatic cancer	6.31e-05	0.000315	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	6.29e-05	0.000314	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	6.2e-05	0.00031	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—KRAS—pancreatic cancer	6.14e-05	0.000307	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TYMP—pancreatic cancer	5.92e-05	0.000296	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	5.91e-05	0.000296	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	5.87e-05	0.000294	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	5.84e-05	0.000292	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SST—pancreatic cancer	5.77e-05	0.000289	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.69e-05	0.000285	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JAG1—pancreatic cancer	5.65e-05	0.000282	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CA—pancreatic cancer	5.64e-05	0.000282	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH3—pancreatic cancer	5.62e-05	0.000281	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	5.6e-05	0.00028	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	5.6e-05	0.00028	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TP53—pancreatic cancer	5.45e-05	0.000273	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CNR1—pancreatic cancer	5.32e-05	0.000266	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HRAS—pancreatic cancer	5.22e-05	0.000261	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CG—pancreatic cancer	5.17e-05	0.000258	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GCG—pancreatic cancer	5.14e-05	0.000257	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SST—pancreatic cancer	5.13e-05	0.000256	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.05e-05	0.000253	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	5.02e-05	0.000251	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CD—pancreatic cancer	5e-05	0.00025	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	4.99e-05	0.00025	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGTR1—pancreatic cancer	4.91e-05	0.000245	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STK11—pancreatic cancer	4.84e-05	0.000242	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	4.77e-05	0.000239	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	4.73e-05	0.000237	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DPYD—pancreatic cancer	4.69e-05	0.000235	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—pancreatic cancer	4.61e-05	0.00023	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	4.59e-05	0.00023	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	4.57e-05	0.000228	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CD—pancreatic cancer	4.54e-05	0.000227	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	4.45e-05	0.000223	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.44e-05	0.000222	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.36e-05	0.000218	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	4.36e-05	0.000218	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	4.29e-05	0.000215	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SMAD4—pancreatic cancer	4.24e-05	0.000212	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—pancreatic cancer	4.19e-05	0.00021	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HES1—pancreatic cancer	4.14e-05	0.000207	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	4.04e-05	0.000202	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CB—pancreatic cancer	3.96e-05	0.000198	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.87e-05	0.000194	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—pancreatic cancer	3.81e-05	0.00019	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	3.76e-05	0.000188	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	3.72e-05	0.000186	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	3.67e-05	0.000184	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TERT—pancreatic cancer	3.62e-05	0.000181	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	3.52e-05	0.000176	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HIF1A—pancreatic cancer	3.47e-05	0.000173	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TSC2—pancreatic cancer	3.46e-05	0.000173	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CD44—pancreatic cancer	3.45e-05	0.000173	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOE—pancreatic cancer	3.38e-05	0.000169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	3.38e-05	0.000169	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KDR—pancreatic cancer	3.31e-05	0.000166	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCG—pancreatic cancer	3.31e-05	0.000165	CbGpPWpGaD
Dextroamphetamine—Pseudoephedrine—TNF—pancreatic cancer	3.23e-05	0.505	CrCbGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	3.22e-05	0.000161	CbGpPWpGaD
Dextroamphetamine—Nateglinide—PPARG—pancreatic cancer	3.17e-05	0.495	CrCbGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NFKBIA—pancreatic cancer	3.15e-05	0.000158	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH1—pancreatic cancer	3.12e-05	0.000156	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—STK11—pancreatic cancer	3.11e-05	0.000155	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	3.08e-05	0.000154	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	3.07e-05	0.000154	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CG—pancreatic cancer	3.05e-05	0.000153	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—NRAS—pancreatic cancer	3.05e-05	0.000153	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGF—pancreatic cancer	3.02e-05	0.000151	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	3e-05	0.00015	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	2.94e-05	0.000147	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	2.8e-05	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	2.78e-05	0.000139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	2.77e-05	0.000139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	2.71e-05	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	2.71e-05	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	2.68e-05	0.000134	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	2.68e-05	0.000134	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.68e-05	0.000134	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.66e-05	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	2.63e-05	0.000131	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	2.47e-05	0.000124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	2.41e-05	0.000121	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	2.38e-05	0.000119	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.36e-05	0.000118	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	2.34e-05	0.000117	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	2.33e-05	0.000117	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	2.25e-05	0.000112	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	2.23e-05	0.000112	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOE—pancreatic cancer	2.18e-05	0.000109	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	2.17e-05	0.000109	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	2.15e-05	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.14e-05	0.000107	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	2.09e-05	0.000105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	2.08e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	2.07e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	2.03e-05	0.000102	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	2.02e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	2e-05	9.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.98e-05	9.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	1.97e-05	9.86e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.96e-05	9.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.93e-05	9.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.91e-05	9.56e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.89e-05	9.48e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	1.87e-05	9.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.86e-05	9.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.84e-05	9.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	1.83e-05	9.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	1.81e-05	9.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.81e-05	9.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	1.8e-05	9.02e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.8e-05	8.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.75e-05	8.76e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.73e-05	8.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	1.68e-05	8.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	1.68e-05	8.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.67e-05	8.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	1.64e-05	8.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.62e-05	8.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.61e-05	8.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.6e-05	8.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	1.55e-05	7.76e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.5e-05	7.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	1.49e-05	7.46e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.49e-05	7.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	1.49e-05	7.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	1.46e-05	7.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	1.43e-05	7.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	1.38e-05	6.9e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	1.38e-05	6.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	1.32e-05	6.6e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.3e-05	6.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.27e-05	6.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	1.23e-05	6.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	1.17e-05	5.86e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	1.16e-05	5.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	1.03e-05	5.17e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	9.17e-06	4.59e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—pancreatic cancer	7.49e-06	3.75e-05	CbGpPWpGaD
